Name
Innovation or Exclusion? Antitrust, Patents and Data in the Next Era of Drug Development
Date & Time
Wednesday, October 21, 2026, 12:55 PM - 1:55 PM
Speakers
Eric Stock, Gibson Dunn
Scott Hemphill, New York University School of Law
Kira Stearns, NERA
Christopher Wilson, Baker Botts
Saami Zain, Office of the New York State Attorney General
Scott Hemphill, New York University School of Law
Kira Stearns, NERA
Christopher Wilson, Baker Botts
Saami Zain, Office of the New York State Attorney General
Description
- Key takeaways from the Amitiza verdict – what does it mean for future enforcement?
- Can the proposed ETHIC Act unlock competition in pharmaceuticals by limiting patent thickets, or will it create unintended consequences for R&D?
- The evolving development between IP rights and antitrust enforcement in life sciences
Session Type
Panel